Titre :
  • Results of randomised phase II studies comparing S16020 with methotrexate in patients with recurrent head and neck cancer.
Auteur : Pivot, X ; Awada, Ahmad ; Gedouin, D ; Kerger, Joseph ; Rolland, Florence ; Cupissol, Didier ; Caponigro, F ; Comella, G ; Lopez-Pousa, J J ; Guardiola, E ; Giroux, B ; Gérard, B. ; Schneider, M
Informations sur la publication : Annals of oncology, 14, 3, (page 373-377)
Statut de publication : Publié, 2003-03
Sujet CREF : Sciences bio-médicales et agricoles
Mots-clés MeSH : Adult
Aged
Antimetabolites, Antineoplastic -- administration & dosage
Antimetabolites, Antineoplastic -- adverse effects
Antimetabolites, Antineoplastic -- therapeutic use
Carbazoles -- administration & dosage
Carbazoles -- adverse effects
Carbazoles -- therapeutic use
Disease Progression
Drug Administration Schedule
Edema -- etiology
Female
Head and Neck Neoplasms -- drug therapy
Head and Neck Neoplasms -- pathology
Humans
Infusions, Intravenous
Injections, Intravenous
Male
Methotrexate -- administration & dosage
Methotrexate -- adverse effects
Methotrexate -- therapeutic use
Middle Aged
Neoplasm Recurrence, Local -- drug therapy
Neoplasm Recurrence, Local -- pathology
Pyridines -- administration & dosage
Pyridines -- adverse effects
Pyridines -- therapeutic use
Survival Analysis
Treatment Outcome
Note : Clinical Trial
Clinical Trial, Phase II
Journal Article
Multicenter Study
Randomized Controlled Trial
Langue :
  • Anglais
Identificateurs : urn:issn:0923-7534 
info:pmid/12598340